Recientemente, se publicaron 52,53 , los resultados del estudio SCALE (Satiety and Clinical Adiposity-Liraglutide Evidence in Nondiabetic and Diabetic Individuals), ensayo clnico aleatorizado, doble ciego, controlado con placebo que incluy 3.731 pacientes obesos con ms de 30 de IMC o con ms de 27 de IMC si tenan dislipidemia o hipertensin tratada o no 52 , y 846 pacientes con DM2 y con IMC igual o mayor a 27 tomando o no agentes hipoglicemiantes y cuyas HbA1 C se encontraban entre 7,0 y 10,0% 53
Does Willow support maintenance treatment
Figure 1) in the GLP-1 stimulatory S
When used in combination, the majority of the antihyperglycemic agents reduced HbA1c to a lesser extent compared to monotherapy [23]
The approval of Wegovy for chronic weight management in 2021 saw traditional drug spending surge
All You Need to Know About the Side Effects of GLP-1 Along with sagging skin, some women experience vaginal dryness and pelvic muscle weakness